Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-03-26Clinical Trial Update: Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures. [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating lipid-emulsion or nanoemulsion propofol in children undergoing ambulatory invasive procedures was with…
-
CLINICAL_TRIALS withdrawal · 2013-12-04Clinical Trial Update: A Study to Evaluate PT-523 in Patients With Refractory Leukemia [Phase 1, Phase 2]
A study evaluating PT-523 in patients with refractory leukemia (Phase 1/Phase 2) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-30Clinical Trial Update: Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia [Phase 3]
A Phase 3 trial investigating intensive glycemic control in patients with acute leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-15Clinical Trial Update: Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders [Phase 1]
A Phase 1 study evaluating phenethyl isothiocyanate for leukemia and other lymphoproliferative disorders was withdrawn. The sponsor was MD A…
-
CLINICAL_TRIALS withdrawal · 2013-04-05Clinical Trial Update: Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload [NA]
A clinical trial evaluating ultrafiltration (Aquapheresis) in patients with leukemia and severe fluid overload has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-04-02Clinical Trial Update: Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer [NA]
Clinical trial evaluating Aprepitant and Ondansetron for opioid-induced nausea and vomiting in cancer patients; the study was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Homoharringtonine for patients with refractory acute promyelocytic leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-07Clinical Trial Update: Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [Phase 1]
Phase 1 study evaluating antiviral therapy plus stem cell transplantation in HIV-positive patients with leukemia or lymphoma has been withdr…
-
CLINICAL_TRIALS withdrawal · 2013-02-15Clinical Trial Update: Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies [Phase 1, Phase 2]
Clinical trial update notes the withdrawal of a Phase 1/2 study evaluating antimicrobial versus saline solutions to maintain catheter patenc…
-
EMA withdrawal · 2013-01-18EMA Application withdrawn: Loulla — Only For Children Pharmaceuticals
The EMA withdrew the application for Loulla from Only For Children Pharmaceuticals for a leukemia/lymphoid therapeutic area.
-
CLINICAL_TRIALS withdrawal · 2012-10-11Clinical Trial Update: Infusion of Expanded Cord Blood T Cells [Phase 1]
A Phase 1 clinical trial evaluating the infusion of expanded cord blood T cells for stem cell transplantation in leukemia has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-02Clinical Trial Update: Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets [Phase 3]
This Phase 3 trial comparing fresh random platelets with autologous thrombosol-treated autologous platelets in patients with leukemia or lym…
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: NOV-002 in Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial of NOV-002 in myelodysplastic syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-20Clinical Trial Update: Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia [Phase 1]
A Phase 1 trial of recombinant human Mannose-Binding Lectin (MBL) in young patients with MBL deficiency and fever with neutropenia was withd…
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: Palifermin After Haploidentical PBSCT [Phase 2]
A Phase 2 trial evaluating palifermin after haploidentical peripheral blood stem cell transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-01-23Clinical Trial Update: Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens [Phase 2]
A Phase 2 study of forodesine hydrochloride in relapsed/refractory precursor T-lymphoblastic leukemia/lymphoma was terminated; no efficacy r…